Cannabis News
The End of the US Hemp Industry is Near
Published
10 months agoon
By
admin
The 2018 Farm Bill legalized the cultivation of hemp, distinguishing it from marijuana based on its low THC content. However, an emerging loophole has allowed the proliferation of psychoactive hemp-derived products, particularly delta-8 THC, which has led to significant regulatory and public health concerns. In response, a proposed amendment to the Farm Bill seeks to address these issues by banning hemp-derived cannabinoid products, including delta-8 THC. This proposed amendment, filed by Rep. Mary Miller (R-IL), aims to redefine hemp and close the existing loophole around intoxicating hemp. The amendment has sparked a heated debate among industry stakeholders, regulators, and lawmakers.
If you have followed the legal hemp market over the past 8 years and attended shows like the Benzinga Cannabis Conference, you know that the only thing keeping the US hemp industry alive, and on life-support at best, is the sale of commerical retail products that create revenue, ie, Delta-8 THC and Delta-9 THC products derived from hemp. While hemp-crete and hemp twine are nice stories, the only “cash crop” hemp has right now is selling “hemp that gets you high” to Americans that don’t have acccess to legal weed.
As mentioned by a few VCs and investment firms at the industry trade shows, the only think keeping hemp alive in America is Delta-8 and Delta-9 THC products and sales.
That “loophole” in the original 2018 Farm Bill may be closing, and for good, with a new amendment put forward this week.
Key Provisions of the Proposed Amendment
The amendment includes several critical provisions designed to tighten regulations on hemp-derived products:
-
Redefinition of Hemp: Redefines hemp to exclude products containing detectable levels of THC and cannabinoids synthesized outside the plant.
-
Ban on Delta-8 THC: Explicitly bans hemp-derived products that contain psychoactive cannabinoids, such as delta-8 THC.
-
Enhanced Regulatory Oversight: Aims to provide clearer guidelines and stricter controls over the production and sale of hemp-derived products.
Concerns Leading to the Amendment
Proponents of the amendment argue that the current lack of regulation has led to several issues:
-
Marketing to Children and Teens: Psychoactive hemp products are often marketed in colorful packaging, resembling candy and snacks, raising concerns about their appeal to children and teenagers.
-
Unregulated Market: The proliferation of hemp-derived cannabinoids has resulted in an unregulated market where the safety and quality of products are inconsistent.
-
Public Health Risks: There are concerns about the potential health risks associated with the unregulated sale and consumption of these products.
Industry Opposition and Concerns
Industry stakeholders and advocates for the hemp industry have voiced strong opposition to the proposed amendment. Their main arguments include:
-
Impact on CBD Products: The amendment could criminalize many non-intoxicating CBD products that naturally contain trace amounts of THC.
-
Economic Consequences: The ban could devastate the hemp industry, resulting in significant job losses and economic decline.
-
Access to Health Products: Many Americans rely on hemp-derived products for health and wellness, and the ban could deny them access to these beneficial products.
Economic Implications
The hemp market is currently valued at approximately $28 billion, with a significant portion of this market driven by hemp-derived cannabinoid products. The proposed amendment could have profound economic implications, including:
-
Job Losses: Potential loss of tens of thousands of jobs in agriculture, retail, and manufacturing sectors.
-
Market Decline: A potential decline in sales and overall market value as many products would no longer be legally available.
-
Investment Uncertainty: Increased regulatory uncertainty could deter future investments in the hemp industry.
Regulatory Challenges
The hemp industry has faced numerous regulatory challenges since the legalization of hemp in 2018. Key regulatory hurdles include:
Lack of FDA Regulation: The FDA has yet to establish clear regulations for hemp-derived CBD products, creating a patchwork of state-level regulations and contributing to market instability.
-
Safety and Quality Standards: The absence of federal guidelines has led to inconsistent safety and quality standards across the industry.
-
Youth Access: The unregulated sale of psychoactive hemp products has raised concerns about youth access and potential misuse.
Legislative Process and Potential Outcomes
The amendment’s approval by the House Agriculture Committee is the first step in a potentially contentious legislative process. The Senate, which has yet to release its version of the Farm Bill, will play a crucial role in determining the amendment’s fate. Key considerations include:
-
Senate’s Stance: The Democratic-controlled Senate may take a different approach to the regulation of hemp-derived cannabinoids, potentially leading to a conflict between the two chambers.
-
Bipartisan Negotiations: Successful passage of the amendment will likely require bipartisan support and negotiations to reconcile differing viewpoints.
-
Final Legislation: The final version of the Farm Bill will need to balance the interests of public health, industry stakeholders, and regulatory clarity.
Broader Implications for Cannabinoid Regulation
The proposed amendment raises broader questions about the regulation of cannabinoids in general:
-
Defining Cannabinoids: The amendment’s language excluding detectable levels of THC and synthesized cannabinoids could impact the regulation of other cannabinoids, such as CBD.
-
Regulatory Parity: Proponents argue that the amendment would create regulatory parity and facilitate state-level regulation of intoxicating hemp products.
-
Future of Cannabinoid Products: The regulation of cannabinoids will continue to evolve, with ongoing debates about the safety, efficacy, and legality of various products.
Public Health Considerations
The shift towards greater regulation of hemp-derived cannabinoids has significant public health implications:
-
Consumer Safety: Enhanced regulatory oversight could improve consumer safety by ensuring that hemp-derived products meet consistent quality and safety standards.
-
Health Risks: The unregulated sale of psychoactive hemp products poses potential health risks, particularly for vulnerable populations.
-
Research and Education: Increased research and public education efforts are needed to fully understand the health impacts of hemp-derived cannabinoids and inform regulatory policies.
Industry Adaptation and Future Outlook
The hemp industry will need to adapt to the proposed regulatory changes if the amendment is enacted. Key strategies for adaptation include:
-
Compliance and Certification: Producers and manufacturers will need to invest in compliance and certification processes to meet new regulatory standards.
-
Product Innovation: The industry may shift focus towards non-psychoactive hemp applications and develop new products that comply with stricter regulations.
-
Advocacy and Engagement: Ongoing advocacy and engagement with policymakers will be essential to ensure that the industry’s interests are represented in regulatory discussions.
Conclusion
The proposed Farm Bill amendment to ban hemp-derived cannabinoid products represents a significant shift in U.S. agricultural and regulatory policy. While proponents argue that it addresses critical public health and safety concerns, industry stakeholders warn of devastating economic consequences and the potential loss of beneficial products. As the amendment moves through the legislative process, the hemp industry faces a period of uncertainty and adaptation. The outcome of this debate will shape the future of hemp regulation, balancing the need for consumer protection with the growth and innovation of a burgeoning industry.
HIGH ON HEMP, YOU BET, READ ON…
You may like
-
Couple arrested with large amounts of weed and molly
-
The Cannabis Rescheduling Ruse – White House Says No Action Planned on Cannabis Reform, Hate to Say I Told You So!
-
Why Quitting Alcohol or Weed Won’t Heal the Pain That Caused You to Start Using Them in the First Place
-
Oklahoma voters could weigh in on adult-use marijuana legalization in 2026
-
Karma Koala Podcast 247: Speaking with Dr. Natalie Corthésy senior lecturer university of West Indies & Enrico Bonadio professor of law City St George’s University of London about their forthcoming Edward Elgar title, “Intellectual Property and Cannabis”
-
MJBizCon offers speakers chance to share cannabis insights, shape industry
Cannabis News
The Cannabis Rescheduling Ruse – White House Says No Action Planned on Cannabis Reform, Hate to Say I Told You So!
Published
1 day agoon
April 5, 2025By
admin
The Rescheduling Ruse: Why I Told You So
In a move that surprised absolutely no one who’s been paying attention, the White House recently announced it has “no action planned” on marijuana reform. Yes, the same marijuana reform that President Trump enthusiastically backed on the campaign trail just weeks before Election Day.
The writing was on the wall all along, folks. I’ve been telling you for months that the much-hyped rescheduling of cannabis from Schedule I to Schedule III was nothing more than political theater – a carefully choreographed dance designed to generate headlines without delivering substantive change. And here we are, with yet another administration putting cannabis reform on the back burner while millions of Americans continue to live under the shadow of failed prohibition policies.
Don’t get me wrong – I’m not here to play political favorites. This isn’t a red versus blue issue. The Biden administration dangled the same carrot, initiating a rescheduling process that conveniently stalled due to “complications” with DEA hearings. Different players, same game.
Let’s take a step back and examine what’s really happening here, because the truth about cannabis reform in America is both simpler and more complex than most people realize.
Trump’s pre-election cannabis conversion was quite the spectacle, wasn’t it? Suddenly, the man who selected Jeff “Good People Don’t Smoke Marijuana” Sessions as his first Attorney General was voicing support for rescheduling, banking access, and even Florida’s legalization initiative.
But as CNN recently reported, “no action is being considered at this time.” The honeymoon didn’t even last through the first dance. The administration’s priorities lie elsewhere – immigration, government spending, foreign policy – while cannabis reform gets shelved alongside countless other campaign promises.
Interestingly, CNN did note that Trump and his transition team attempted to include cannabis banking protections in December’s government funding resolution. This behind-the-scenes effort suggests at least some genuine interest in the issue, but hardly qualifies as the bold reform millions of voters were led to expect.
This pattern should feel familiar. The Biden administration made similar overtures, with the president announcing pardons for federal marijuana possession offenses and directing an administrative review of cannabis scheduling. That process dragged on for over a year, with the DEA repeatedly delaying final action. Biden got the headlines; cannabis users got nothing.
The harsh reality? Cannabis reform makes for good campaign fodder, but terrible governance priorities. Once elected, the political calculus changes dramatically. The motivation to deliver evaporates when the votes are already counted and the special interests start calling in their favors.
At the heart of this perpetual delay lies the Drug Enforcement Administration – an agency whose very existence depends on the continuation of the drug war. Expecting the DEA to facilitate cannabis reform is like asking a turkey to vote for Thanksgiving.
The DEA has mastered the art of procedural obstruction. Under Biden, they scheduled hearings, requested extensions, and effectively ran out the clock. Under Trump, they appear poised to do absolutely nothing, perhaps not even bothering with the pretense of consideration.
The pattern becomes clearer when you look at Trump’s cabinet picks. His nominee to lead the DEA, Terrance Cole, has previously voiced serious concerns about marijuana dangers and linked its use to higher suicide risk among youth. His HHS general counsel nominee, Mike Stuart, is so staunchly anti-cannabis that prohibitionist groups openly celebrated his selection.
Even Robert F. Kennedy Jr., who previously supported legalization, has walked back his stance since being confirmed as HHS Secretary, stating he’s “worried about” high-potency marijuana and deferring to the DEA on rescheduling.
When you stack the regulatory deck with cannabis skeptics, you’ve telegraphed your true intentions no matter what you said on the campaign trail.
Here’s what I’ve been saying all along: meaningful cannabis reform was never going to come from the White House, regardless of who occupied it. The DEA will never willingly relinquish its power, and politicians will always prioritize easier wins over controversial reforms.
The only real path forward is through Congress completely removing cannabis from the Controlled Substances Act. Full stop. No rescheduling, no administrative reviews, no half-measures. Cannabis needs to be descheduled entirely, returning regulatory authority to the states where it belongs.
But while we push for that goal, the real revolution continues on two fronts.
First, state-by-state legalization marches forward. Despite federal inaction, 38 states have medical marijuana programs, and 24 states plus DC have legalized adult use. Each new state that joins the ranks weakens prohibition’s grip and demonstrates the failure of federal policy.
Second, and perhaps more powerful, is what I call “mass defiance of an unjust law.” Every day, millions of Americans peacefully consume cannabis in direct violation of federal law. They grow it in their homes, share it with friends, and build communities around it. This civil disobedience at scale is perhaps the most effective weapon against prohibition.
The federal government simply doesn’t have the resources to enforce cannabis prohibition against a population that increasingly rejects it. When enough people break an unjust law, the law itself becomes unenforceable.
I hate to say I told you so, but… I told you so. The rescheduling promise was never going to materialize, regardless of who won the White House. It was a political mirage, designed to attract voters while requiring minimal commitment.
But don’t mistake my cynicism about federal action for pessimism about our cause. Cannabis reform is happening – it’s just happening from the ground up rather than the top down. Every state that legalizes, every municipality that decriminalizes, every voter who demands change, and yes, every person who peacefully consumes despite prohibition is part of this unstoppable movement.
The lesson here is simple: Don’t put your faith in presidential promises or administrative processes. Put it in your local ballot initiatives, your state legislators, and your own power to reject unjust laws through peaceful non-compliance.
Cannabis prohibition is dying, not because presidents commanded it, but because we the people have decided it must end. That’s the real power in our democracy – not the fleeting promises of politicians, but the sustained will of the citizens.
So next time a candidate promises to fix cannabis laws, remember this moment. Then go out and fix them yourself, one vote, one state, and one act of principled defiance at a time. That’s how real change happens in America, and that’s how we’ll finally end cannabis prohibition once and for all.
CANNABIS UNDER TRUMP 2.0, READ ON…
Cannabis News
Why Quitting Alcohol or Weed Won’t Heal the Pain That Caused You to Start Using Them in the First Place
Published
1 day agoon
April 5, 2025By
admin
Quitting Won’t Fill the Hole
There’s a pervasive notion that floats around recovery circles—this idea that once you kick your habit, everything will magically fall into place. The clouds will part, the birds will sing, and suddenly life will be worth living again. While it’s true that being addicted to a “thing,” whether substance or act, eventually tallies up consequences that weigh heavy on our souls, the math isn’t quite as simple as “remove addiction, add happiness.”
I’ve watched countless cannabis enthusiasts (and addicts of all stripes) fall into this trap. They sit in circles, eyes gleaming with hope as they declare, “If I could only quit, then everything would be better…” But they’re missing something crucial—their addiction isn’t the source of their discontent; it’s merely a symptom of something deeper.
Addiction, at its core, is a means of dealing with something we cannot name or are desperately trying to avoid. It’s the bandage we slap over a wound without cleaning it first. The cannabis, the alcohol, the gambling, the endless scrolling—these aren’t the disease itself but rather the body’s misguided attempt at self-medication.
Here’s the uncomfortable truth that most recovery programs don’t emphasize enough: if you don’t do the real healing, even if you manage to white-knuckle your way through quitting one addiction, you’ll inevitably find something else to cover that gaping wound. Maybe you’ll trade joints for junk food, or bongs for binge-watching. The face of the addiction changes, but the role it plays remains constant.
Let’s take a deeper dive into this cycle and why simply quitting isn’t enough to truly heal.
First, we must acknowledge that when it comes to pain and addiction, everyone’s journey is unique. What feels like an insurmountable mountain to you might be a speed bump to someone else, and vice versa. There’s no universal scale for suffering, which makes navigating these waters all the more complex.
However, across all these varied experiences, there’s a common trap I’ve seen ensnare countless individuals—what I call the “If/Then Fallacy.” It’s the belief that one singular thing is the root cause of all our discomfort. This is where addicts often say, “If I can only kick this addiction, then my whole life would be better.” While this may seem logical on paper, it’s a deeply flawed perspective.
The real issue rarely lies with the substance or behavior itself but with something deeper—something the addiction is helping us avoid or cope with. Whether it’s trauma, depression, anxiety, or simply the existential weight of being human in an increasingly disconnected world, there’s usually a wound beneath the bandage.
Furthermore, the “If/Then” scenario places your healing, joy, and accomplishments in a fictional future state. “If I stop smoking weed, then I’ll finally have the motivation to start that business.” “If I quit drinking, then my relationship will improve.” These statements create a dangerous binary—because when the “if” is satisfied but the “then” doesn’t materialize, where does that leave you? Often, it leads to “If that didn’t work, then what’s the point of trying anything?”
This thinking creates a perfect setup for relapse or substituting one addiction for another. After all, if quitting didn’t magically transform your life as promised, why continue to deny yourself that temporary relief?
If you’ve been considering quitting cannabis or any other addiction, and you believe it to be the sole source of your unhappiness, I strongly urge you to reconsider your framework. The cannabis, or your relationship with it, is likely just a mask for your real pain. If you want to truly liberate yourself from the burden of addiction, you need to develop the capacity to sit with your pain, examine it, and cultivate joy despite it—not because it disappeared.
This article was inspired by a post I came across while scrolling through Reddit the other day—one of those moments where someone’s raw honesty stops you mid-scroll. A 32-year-old man shared that after smoking cannabis and drinking 4-6 beers daily for nearly his entire 20s, he had finally managed to quit both. No cannabis for almost six months, no alcohol for three. A significant achievement by any measure.
Yet instead of the transformation he expected, he felt “MISERABLE.” Despite taking medication for ADHD and anxiety, and despite removing substances that conventional wisdom says should improve his mental health, he felt no positive change. In fact, he felt worse, as if he’d “stopped doing things that were fun for me, or at least making life bearable.”
His post ended with a plea that broke my heart: “Is this just how I’m going to feel now? Does this go away eventually?”
This redditor’s experience perfectly illustrates the point—even when you manage to power through the physical and psychological challenges of quitting an addiction, your mental and spiritual state doesn’t necessarily transform as a result. His baseline remained exactly the same, perhaps even dipping lower without the chemical crutches he’d relied on for so long.
When you’re changing habits but not experiencing the promised benefits, it’s a clear sign that your discomfort or pain isn’t primarily coming from the substance. The cannabis or alcohol wasn’t creating your misery—it was masking it, providing temporary relief from a deeper issue that remains unaddressed.
This is something we all must consider when facing our compulsions. If you find yourself in a situation where you want to stop a behavior but simply can’t, it might be time to look deeper. Ask yourself, “Why do I do this activity?” And then ask “why” five more times, each answer digging a layer deeper toward the root cause.
Why do I smoke cannabis every night? Because it helps me relax. Why do I need help relaxing? Because my mind races with anxiety. Why does my mind race with anxiety? Because I’m worried about my future. Why am I worried about my future? Because I don’t feel secure in my career path. Why don’t I feel secure in my career path? Because I never really chose it—I fell into it. Why does that bother me? Because I feel like I’m not living authentically or pursuing my true passions.
Once you’ve excavated to this deeper level, you can begin to address the root causes directly. Perhaps the issue isn’t the cannabis at all, but rather that you need to reassess your career path or find meaning outside of work. Without this deeper work, quitting the substance becomes an exercise in willpower rather than healing.
Your addiction isn’t necessarily the root cause of your issues—it’s often just the most visible symptom. If you’re depressed, anxious, or feeling lost, it’s not primarily because of the substance; it’s because of something deeper that the substance helps you manage or forget temporarily.
Unless you actually do the internal work on these matters—examining your pain, seeking appropriate mental health support, rebuilding healthy relationships, finding meaning and purpose—no matter what you quit or how long you stay “clean,” you’ll likely find yourself seeking new ways to shield yourself from the pain. The prison isn’t cannabis or alcohol; it’s the unhealed wound those substances help you endure.
If you’re struggling right now, it’s absolutely important to seek help. That might mean therapy, support groups, or speaking with a healthcare provider about potential underlying mental health conditions that need treatment. But alongside that external support, commit to the honest and difficult work of looking inward. Ask yourself what you’re truly trying to avoid when you reach for that joint or that drink.
At the end of the day, we all have our struggles. If yours involves cannabis at this point in your life, there’s no judgment here. I’ve been there myself. But I’ve also learned that true healing rarely comes from simply removing something from your life—it comes from adding understanding, self-compassion, and addressing the real gaps in your heart and mind that the substance was never capable of filling in the first place.
The void can’t be filled by quitting. But quitting might just give you the clarity to finally see what the void truly needs.
QUITTING CANNABIS, READ ON…
THE STONER’S GUIDE TO QUITTING WEED – WAIT, WHAT…WHY?
Cannabis News
Scientists Now Think That One Compound in the Cannabis Plant Can Replace All Opiates
Published
3 days agoon
April 3, 2025By
admin
Which Cannabis Compound Do Scientists Think Can Replace Opiates?
…And Why This Is Important
Opiates are a type of pharmaceutical drug that’s been made from the opium poppy plant. While it’s somewhat a ‘natural’ substance that’s been extracted from the fibers and sap of the opium poppy plant, these are extremely dangerous sedatives that act on the central nervous system. However, there are completely synthetic opioids as well, which are manufactured entirely in laboratories.
Famous examples of well-known and widely-used opiates today include heroin, codeine, and morphine. They all work similarly, binding to the brain’s opioid receptors and users feel a drastic reduction in pain. It also causes users to feel euphoric, drowsy, or sleepy. Common side effects include constipation and nausea.
Because opiates are powerful for dulling one’s pain perceptions, they have become commonly prescribed by doctors and hospitals for pain relief. That said, opiates have become one of the world’s most addictive, dangerous, and fatal drugs – and you can get prescribed it right by your very own physician. Repeated use of opiates can easily lead to dependence and addiction, and eventually consuming high doses can drastically slow down breathing, and cause brain damage, or even death.
Since doctors still keep prescribing opioids, this has resulted in the deadly Opioid Epidemic, which has killed thousands of people. It’s a worrisome public health crisis, most especially because of fentanyl, an illegally manufactured opioid which is said to be 50 times more potent than heroin.
Could The Answer To The Opioid Epidemic Lie In Cannabis…Terpenes?
The past few years have shown that cannabis legalization is critical for surviving the opioid epidemic, and reducing overall opioid consumption.
The results of a recent research paper, which builds on past studies conducted by Dr. John Streicher, who is a member of the Comprehensive Center for Pain and Addiction, reveals fascinating findings. According to Streicher, cannabis terpenes were found to provide relief in inflammation models as well as on neuropathic pain caused by chemotherapy.
For the study, Streicher and his research team analyzed 4 kinds of terpenes that are found in mid to high levels in Cannabis sativa plants: linalool, geraniol, beta-caryophyllene, and alpha-humulene. They discovered that each terpene produced significant pain relief among mice subjects with fibromyalgia and post-operative pain, and among the terpenes, geraniol was found to be the most powerful.
“Our research is showing that terpenes are not a good option for reducing acute pain resulting from an injury, such as stubbing your toe or touching a hot stove; however, we are seeing significant reductions in pain when terpenes are used for chronic or pathological pain,” he said. “This study was the first to investigate the impact of terpenes in preclinical models of fibromyalgia and post-operative pain and expand the scope of potential pain-relieving treatments using terpenes,” Streicher said.
Cannabis terpenes are the compounds responsible for the aromatic profile of each strain; they are located in the plant trichomes. Not only do they contribute to each strain’s unique flavor and odor, but they also have valuable therapeutic and medicinal benefits. There are around 150 kinds of terpenes known today, though in the entire plant world, there are known to be some 20,000 terpenes.
Understanding the therapeutic benefits of terpenes is incredibly valuable also because they don’t contain THC (tetrahydrocannabinol), the compound in marijuana that gets you high.
“With fibromyalgia, there isn’t much of an understanding of what the pain state is, and there are not a lot of great options for treating it,” explains Streicher. “Our findings show that terpenes may be a viable treatment option for fibromyalgia pain, which could potentially have a large impact and make a difference for an under-treated population.”
Other Studies
This is not the first time that cannabis terpenes have been found to demonstrate excellent pain-relieving properties. It must be noted that just like what Streicher says, terpenes seem to do better with chronic pain management, instead of acute pain management.
Another study from 2024, which was published in The Journal of the Association for the Study of Pain, was conducted by researchers at the University of Arizona and the National Institutes of Health. The investigators analyzed the analgesic properties of different terpenes including geraniol, humulene, linalool, pinene, and caryophyllene among mice subjects with chemotherapy-induced peripheral neuropathy.
According to the researchers, all the terpenes delivered analgesic effects that were equivalent to around 10 mg/kg of morphine. It was also interesting to note that administering both morphine and terpenes together at low doses resulted in ‘enhanced’ pain-killing effects.
“Together these studies identify cannabis terpenes as potential therapeutics for chronic neuropathic pain,” said the investigators.
There have also been other studies that have found that combining cannabis with opioids can indeed provide long-lasting pain relief. It comes with the added benefit of reducing opioid doses needed for effective pain control. This phenomenon is called opioid-sparing. These types of protocols can be beneficial for patients who suffer from severe, chronic pain caused by cancer, arthritis, joint problems, fibromyalgia, diabetes, post-surgical pain, migraines, nerve damage, and so much more.
Conclusion
Learning more about the pain-killing properties of terpenes is extremely valuable for the medical community, patients, and even society as a whole. We can all do with less opioid addictions because it has torn families apart, and caused the deaths of thousands of people.
Terpenes, or cannabis in general, offer a natural and safe alternative that can be complementary to other pharmaceutical treatments designed to reduce pain.
SWAPPNG OPIOIDS FOR CANNABIS, READ ON…

Couple arrested with large amounts of weed and molly

The Cannabis Rescheduling Ruse – White House Says No Action Planned on Cannabis Reform, Hate to Say I Told You So!

Why Quitting Alcohol or Weed Won’t Heal the Pain That Caused You to Start Using Them in the First Place

Oklahoma voters could weigh in on adult-use marijuana legalization in 2026

Karma Koala Podcast 247: Speaking with Dr. Natalie Corthésy senior lecturer university of West Indies & Enrico Bonadio professor of law City St George’s University of London about their forthcoming Edward Elgar title, “Intellectual Property and Cannabis”

MJBizCon offers speakers chance to share cannabis insights, shape industry

The Best Tariff Friendly Cocktails

Cannabis Consumers Are Being Hit By The Tariffs

The Best Tips To Update Your Wardrobe

Former New York Knick Iman Shumpert debuts ‘TSA Approved’ legal cannabis brand

Distressed Cannabis Business Takeaways – Canna Law Blog™

United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)

What you Need to Know

Drug Testing for Marijuana – The Joint Blog

NCIA Write About Their Equity Scholarship Program

It has been a wild news week – here’s how CBD and weed can help you relax

Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022

A new April 20 cannabis contest includes a $40,000 purse

Your Go-To Source for Cannabis Logos and Designs

UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing1 year ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse